G1 Therapeutics Inc.
G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer.
Company Location
700 Park Offices Drive, Suite 200
Research Triangle Park
NC
27709
P.O. Box 110341
Research Triangle Park
NC
27709
Phone
County
Region
Company Details
Company type
Year founded
2008
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products on market
COSELA (trilaciclib), a myeloprotection therapy for decreasing incidence of chemotherapy-induced myelosuppression in patients with extensive stage small cell lung cancer
Products under development
Trilaciclib